GLP-2 TR-10

Overview

Tirzepatide is a synthetic peptide studied exclusively in non-clinical and preclinical research environments. It functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Research investigates Tirzepatide’s effects on metabolic and cellular signaling pathways under controlled laboratory conditions, with particular focus on its modulation of insulin sensitivity, glucose metabolism, and receptor-binding dynamics in non-human experimental models.

Specifications

• Unit Size: 10 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

Preclinical and in vitro studies have explored Tirzepatide in relation to:

• Dual receptor activation of GIP and GLP-1 pathways in cell and animal models

• Glucose uptake and insulin signaling regulation under experimental conditions

• Metabolic homeostasis and bioenergetic regulation in laboratory systems

• Cellular pathway modeling for peptide receptor binding and activation

All references and findings originate from controlled laboratory studies only. These investigations do not represent or imply safety, efficacy, or intended medical use in humans or animals.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Buyer must be a qualified researcher or institution and assumes all responsibility for lawful handling and compliance with institutional and governmental regulations.

Important Notice

The information presented is provided strictly for scientific and educational purposes. The seller makes no representations regarding the safety, therapeutic value, or suitability of this material for any clinical or personal use. Tirzepatide is not approved for human or veterinary administration. Proper storage, handling, and disposal must follow institutional biosafety procedures.